NEW YORK, NY
Allocation by class
Portfolio Concentration
Top 3 weight
27.2%
Top 10 weight
65.8%
Voting Authority Distribution
Total shares with voting rights: 41.06M
Full voting authority
41.06M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELMADA THERAPEUTICS INCSOLE | COM | 6.26M | SH | $43.00M 10.34% | 6.26M | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS ISOLE | ORD SHS CL A | 761.06K | SH | $36.65M 8.81% | 761.06K | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.38M | SH | $33.64M 8.09% | 1.38M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INSOLE | COM | 373.27K | SH | $31.33M 7.53% | 373.27K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 2.98M | SH | $29.69M 7.14% | 2.98M | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 1.33M | SH | $29.12M 7.00% | 1.33M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | SPONSORED ADS | 489.85K | SH | $19.46M 4.68% | 489.85K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.38M | SH | $18.47M 4.44% | 3.38M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALSSOLE | COM | 897.68K | SH | $18.07M 4.34% | 897.68K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 245.71K | SH | $14.28M 3.43% | 245.71K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 329.01K | SH | $12.90M 3.10% | 329.01K | 0.00 | 0.00 |
SURROZEN INC COM NEWSOLE | COM NEW | 432.04K | SH | $12.59M 3.03% | 432.04K | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS ISOLE | COM | 932.60K | SH | $11.78M 2.83% | 932.60K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 317.99K | SH | $11.24M 2.70% | 317.99K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICSSOLE | COM NEW | 2.63M | SH | $10.96M 2.63% | 2.63M | 0.00 | 0.00 |
MINERVA NEUROSCIENCSOLE | COM NEW | 1.66M | SH | $9.97M 2.40% | 1.66M | 0.00 | 0.00 |
CENTURY THERAPEUTICSSOLE | COM | 4.06M | SH | $9.17M 2.21% | 4.06M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 392.57K | SH | $8.65M 2.08% | 392.57K | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INSOLE | COM NEW | 2.20M | SH | $8.42M 2.02% | 2.20M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 422.54K | SH | $6.84M 1.64% | 422.54K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTISOLE | COM NEW | 3.58M | SH | $6.02M 1.45% | 3.58M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 200K | SH | $5.97M 1.44% | 200K | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 1.66M | SH | $5.58M 1.34% | 1.66M | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 928.59K | SH | $5.33M 1.28% | 928.59K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIISOLE | USD CL A ORD SHS | 500K | SH | $5.08M 1.22% | 500K | 0.00 | 0.00 |